– Linda Powers, Cofounder and Managing Director of Toucan Capital, is interviewed by GEN’s Editor in Chief, John Sterling

PodcastsResourcesCell therapyClinical trialDrug research and developmentEmbryonic stem cellsGenetic engineeringGenetic Engineering and BiotechnologyMedicineMedicine, Diagnosis, and TherapeuticsPharmacologyPluripotent stem cellsRegenerative engineeringResearch and developmentResearch resourcesStem cell engineeringStem cellsTherapeuticsTranslational medicine
Previous articleScientists Disprove Proposed Theory of Nervous System Development
Next articleThe Genome Center at Washington University Adds 21 Illumina Sequencers